Effect of Vascular Endothelial Growth Factor and Its Receptor Inhibitor on Proliferation and Invasion in Bladder Cancer

Publisher： Karger

E-ISSN： 1423-0399|83|1|98-106

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.83, Iss.1, 2009-07, pp. : 98-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autocrine Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2 Growth Pathway Represents a Cyclooxygenase-2-Independent Target for the Cyclooxygenase-2 Inhibitor NS-398 in Colon Cancer Cells

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 204-211

Karger

Access to resources Recommend Favorite

A Case Report of Ischemic Stroke in a Patient with Metastatic Gastric Cancer Secondary to Treatment with the Vascular Endothelial Growth Factor Receptor-2 Inhibitor Ramucirumab

By  

Case Reports in Oncology, Vol. 9, Iss. 2, 2016-06 ,pp. : 317-320

Karger

Access to resources Recommend Favorite

Expression of Vascular Endothelial Growth Factor, Receptor KDR and p53 Protein in Transitional Cell Carcinoma of the Bladder

By  

Urologia Internationalis, Vol. 81, Iss. 1, 2008-07 ,pp. : 72-76

Karger

Access to resources Recommend Favorite

Co-Expression of Vascular Endothelial Growth Factor and Its Receptor flt-1 in Malignant Pleural Mesothelioma

By  

Respiration, Vol. 67, Iss. 1, 2000-02 ,pp. : 36-40

Karger

Access to resources Recommend Favorite

The Mitogenic Effect of 17β-Estradiol on in vitro Endothelial Cell Proliferation and on in vivo Reendothelialization Are Both Dependent on Vascular Endothelial Growth Factor

By  

Journal of Vascular Research, Vol. 37, Iss. 3, 2000-05 ,pp. : 202-208

Karger

Access to resources Recommend Favorite